Edgewise Therapeutics Inc at Stifel CNS Days (Virtual) Transcript
Great. Good afternoon, everybody. It's my pleasure to be hosting the Edgewise Therapeutics team. With me is Kevin and Behrad. They're going to give an overview of the company for about 15 minutes or so, and then we can do Q&A. (Conference Instructions)
So Kevin, I can turn it over to you, and thank you again for taking the time to join us. Appreciate it.
Great, Paul. Thank you very much. This is Edgewise Therapeutics. I'm Kevin Koch, the CEO. This is my disclaimer for what I'll be telling you today.
So Edgewise. Experienced management team with deep expertise in muscle physiology and biology targeting rare muscle disorders. We work almost entirely on novel targets to optimize our ability to provide benefit to the patients and differentiated benefit to the patients. We believe our first program 5506 can become a foundational therapy for multiple muscular dystrophies because of the ability to work across mutations in this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |